Cargando…

FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer

Epithelial–mesenchymal transition (EMT) is important for tumour cell invasion and metastasis and is a feature of aggressive carcinomas. EMT is characterised by reduced E‐cadherin and increased N‐cadherin expression (EN‐switch), and increased expression of the EMT‐regulating transcription factor Fork...

Descripción completa

Detalles Bibliográficos
Autores principales:	Børretzen, Astrid, Gravdal, Karsten, Haukaas, Svein A, Beisland, Christian, Akslen, Lars A, Halvorsen, Ole J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817834/ https://www.ncbi.nlm.nih.gov/pubmed/31464093 http://dx.doi.org/10.1002/cjp2.142

Ejemplares similares

The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients
por: Børretzen, Astrid, et al.
Publicado: (2021)

Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer
por: Børretzen, Astrid, et al.
Publicado: (2023)

A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary prostate biopsy
por: Nygård, Yngve, et al.
Publicado: (2016)

Optimising preoperative risk stratification tools for prostate cancer using mpMRI
por: Reisæter, Lars A. R., et al.
Publicado: (2017)

A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer
por: Thomsen, Liv Cecilie Vestrheim, et al.
Publicado: (2023)

Mesenchymal-Epithelial Transition in epithelial response to injury: the role of Foxc2
por: Hader, Carlos, et al.
Publicado: (2009)

PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression
por: Sui, Lufei, et al.
Publicado: (2022)

Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties
por: Paranjape, A N, et al.
Publicado: (2016)

Genome-Wide Profiling of Histone H3 Lysine 4 and Lysine 27 Trimethylation Reveals an Epigenetic Signature in Prostate Carcinogenesis
por: Ke, Xi-Song, et al.
Publicado: (2009)

Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target
por: Castellón, Enrique A., et al.
Publicado: (2022)

Digitoxin Inhibits Epithelial-to-Mesenchymal-Transition in Hereditary Castration Resistant Prostate Cancer
por: Pollard, Bette S., et al.
Publicado: (2019)

FOXC2 augments tumor propagation and metastasis in osteosarcoma
por: Gozo, Maricel C., et al.
Publicado: (2016)

FOXC1 Contributes To Microvascular Invasion In Primary Hepatocellular Carcinoma Via Regulating Epithelial-Mesenchymal Transition
por: Xu, Zhi-Yuan, et al.
Publicado: (2012)

De-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells
por: Ren, Yan-hua, et al.
Publicado: (2014)

FOXC1 silencing inhibits the epithelial-to-mesenchymal transition of glioma cells: Involvement of β-catenin signaling
por: Cao, Qinchen, et al.
Publicado: (2019)

Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
por: Jolly, Mohit Kumar, et al.
Publicado: (2015)

Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer
por: Li, Ping, et al.
Publicado: (2014)

HDAC Inhibition Impedes Epithelial-Mesenchymal Plasticity and Suppresses Metastatic, Castration-Resistant Prostate Cancer
por: Ruscetti, Marcus, et al.
Publicado: (2015)

FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer
por: Chen, Yihong, et al.
Publicado: (2020)

Foxc1 dependent mesenchymal signalling drives embryonic cerebellar growth
por: Haldipur, Parthiv, et al.
Publicado: (2014)

Loss of FOXC1 contributes to the corneal epithelial fate switch and pathogenesis
por: Li, Mingsen, et al.
Publicado: (2021)

Foxc1 and Foxc2 in the Neural Crest Are Required for Ocular Anterior Segment Development
por: Seo, Seungwoon, et al.
Publicado: (2017)

Loss of Foxc1 and Foxc2 function in chondroprogenitor cells disrupts endochondral ossification
por: Almubarak, Asra, et al.
Publicado: (2021)

Foxc2 regulates osteogenesis and angiogenesis of bone marrow mesenchymal stem cells
por: You, Wulin, et al.
Publicado: (2013)

Casein Kinase 2 prevents mesenchymal transformation by maintaining Foxc2 in the cytoplasm
por: Golden, Diana, et al.
Publicado: (2014)

BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer
por: Shafran, Jordan S., et al.
Publicado: (2020)

Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
por: Katano, Atsuto, et al.
Publicado: (2021)

All eyes on FOXC2
por: Yan, Wei, et al.
Publicado: (2023)

Hypo- and Hypermorphic FOXC1 Mutations in Dominant Glaucoma: Transactivation and Phenotypic Variability
por: Medina-Trillo, Cristina, et al.
Publicado: (2015)

Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation
por: Ke, Xi-Song, et al.
Publicado: (2008)

Endothelial FOXC1 and FOXC2 promote intestinal regeneration after ischemia–reperfusion injury
por: Tan, Can, et al.
Publicado: (2023)

SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer
por: Qi, Honggang, et al.
Publicado: (2017)

“Prostate telocytes change their phenotype in response to castration or testosterone replacement”
por: Felisbino, Sérgio Luis, et al.
Publicado: (2019)

ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT)
por: Choi, Jae Duck, et al.
Publicado: (2021)

Functional polymorphisms in FOXC2 gene and Epithelial ovarian Cancer susceptibility in Chinese population
por: Zhou, Zhijiao, et al.
Publicado: (2020)

Three cases of brain metastasis from castration‐resistant prostate cancer
por: Shida, Yohei, et al.
Publicado: (2019)

Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2
por: Sarkar, Phoebe L., et al.
Publicado: (2019)

MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
por: Huang, Hui, et al.
Publicado: (2020)

Foxc2 is essential for podocyte function
por: Nilsson, Daniel, et al.
Publicado: (2019)

Regulation and Function of FOXC1 in Osteoblasts
por: Suthon, Sarocha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0m35jveph7blcb24q9qd8sl7v1